 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval% ]. J/ u; G, s4 L6 H4 H
( p2 D: M( F% A& W1 \
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.9 h; o/ x* l, {) q2 B
- ]6 m+ K+ \0 S8 ]% o, t5 o
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007. Y. H% X5 _. Q- ^$ u) m) n& D: e
3 S; h! B( p) K; M- L! t- U
2 A" H7 E j" W$ JEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
/ e9 A6 s* G* k6 F
; a. s. D. f6 n1 V3 vThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
$ N4 ^; s- s3 v+ M
: `+ h8 C0 }: p E3 g1 cThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
+ {- q4 j, ?. i; w5 w& `, W* y
3 _1 ^5 U7 a* N% L8 rIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.0 I8 P+ G( M, c* s/ X3 L# X. v
' b5 I1 q! w1 s" W& f9 G( z. L. j, yIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
8 c% L& r. Q |% P2 X, l2 m P/ H! W' v. n3 z7 ]# V
"As a scientist, it's one of the highlights of my CAREER," Shan said.
; I+ u3 Y& B! Z- Q& ^" R: g7 @) Z9 r; C& G5 H
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."- O1 G) {" {: |$ E, K
$ b/ j* Q+ ^- L* A7 v+ LIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
8 y$ p. y0 U5 f" W* s5 h T) {0 `8 j' L
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
9 N. H. B+ B# p6 [! e3 F& G1 `) ]2 }/ t$ j4 Q) R& t* m# i
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
0 S# q5 t( K2 I$ u
; S8 a, v3 I8 C0 {: U1 g* U% o7 l" B+ N& y1 S5 k
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
8 C9 t/ i3 g# P$ g6 I+ _
发表于 2015-2-28 19:45
